XORTX THERAPEUTICS INC (XRTX)

CA98420Q3061 - Common Stock

2.5615  +0.01 (+0.45%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
6.05M10.29M2.69M1.04M565.97K
Research and Development
2.42M6.76M628.82K207.20K39.90K
Selling, General, and Administrative Expenses
3.49M3.47M2.05M820.03K506.17K
Operating Income
-6.05M-10.29M-2.69M-1.04M-565.97K
Interest Income/Expense
3.89M3.50M2.67M-7.25K-61.98K
Other Income/Expense
0.00-926.46K-1.20M-635.00-1.64K
Non Recurring Items
N/A0.000.0091.06K0.00
Income Before Taxes
-2.16M-7.72M-1.22M-959.30K-629.58K
Net Income
-2.16M-7.72M-1.22M-959.30K-629.58K
EBITDA
-5.91M-10.23M-2.68M-1.03M-546.07K
 
Per Share Data
EPS Diluted Total Ops
-1.09-5.22-1.11-1.30-0.12
 
Statistics

All data in USD

Charts